Supernus Pharmaceuticals | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Abbott USD 40.03B 468M 2024-12
ANI Pharmaceuticals USD 403.68M 2.27M 2024-12
Aurora Cannabis CAD 572.92M 29.75M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Canopy Growth CAD 591.48M 81.81M 2024-12
Corcept Therapeutics USD 679.59M 40.75M 2024-12
Eisai JPY 873.36B 53.3B 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
Indivior -167000000 46M 2024-09
Novo Nordisk 120.52B 8B 2024-09
Pacira USD 778.35M 28.76M 2024-12
Perrigo USD 4.32B 246.6M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12
United Therapeutics USD 6.44B 343.1M 2024-12
Xeris Pharmaceuticals USD -29615000 1.29M 2024-12



Supernus Pharmaceuticals Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.